Holen Sie sich die Stockscreener-App
78.50
2.81%
-2.27
Handel nachbörslich:
78.50
Überblick
Nachrichten
Preisverlauf
Optionskette
Financials
Warum fällt ALC?
Forum
Prognose
Dividendenhistorie
Alcon Inc Aktie (ALC) Neueste Nachrichten
ALC.SW Alcon Inc. (SIX) closes CHF62.56 on 11 Mar 2026: watch analyst targets - Meyka
RSI Check: Will Alcon Inc benefit from green energy policiesTrade Exit Summary & Long-Term Capital Growth Ideas - baoquankhu1.vn
UBS names Alcon top pick, sees strong catalyst path ahead - Investing.com
UBS reiterates Buy on Alcon stock, sees earnings beats ahead By Investing.com - Investing.com Australia
UBS reiterates Buy on Alcon stock, sees earnings beats ahead - Investing.com
Alcon Launches Hydrus Microstent in India to Advance Long-Term Glaucoma Management - eHealth Magazine
Bernstein Says Alcon Top Pick in European Medtech Coverage, Notes 'Good Momentum' for Key Products into FY26 - marketscreener.com
Stifel Raises Alcon (ALC) Price Target to $82, Maintains 'Hold' Rating | ALC Stock News - GuruFocus
Glaucoma Research Foundation and Alcon Partner to Expand Access to Trusted Glaucoma Education - The Manila Times
What Analysts Are Saying About Alcon Stock - Benzinga
Stifel raises Alcon stock price target to $82 on sales growth - Investing.com
Bernstein SocGen names Alcon stock top European medtech pick - Investing.com
Hedge Fund Bets: Can Alcon Inc outperform in the next rallyEarnings Miss & AI Enhanced Trading Alerts - baoquankhu1.vn
What analyst consensus implies for Alcon Inc. (2U3) stock2025 Pullback Review & Stock Portfolio Risk Control - Naître et grandir
Berenberg Keeps Alcon at Buy Amid Signs of US Cataract Market Rebound - marketscreener.com
Precision Trading with Alcon Inc. (ALC) Risk Zones - Stock Traders Daily
Alcon Earnings Report: Q4 Overview - Benzinga
Assessing Alcon (SWX:ALC) Valuation After Earnings Beat, Dividend Proposal And Intraocular Lens Momentum - simplywall.st
Alcon (SWX:ALC) Valuation Check After Earnings Strength And Analyst Optimism - Yahoo Finance
Systane eye drops: Are Alcon’s German bestsellers worth it in the US? - AD HOC NEWS
Alcon Kept at Outperform as RBC Notes 'Positive Setup' Through FY26; Estimates Revised - marketscreener.com
ALCAlcon Announces Amended Merger Agreement with STAAR Surgical - Revista ADVFN
Alcon Reports Second-Quarter 2025 Results, Launched Tryptyr and Announced Acquisition of STAAR Surgical - mx.advfn.com
Alcon Inc. (ALC) Stock Analysis: Eyeing A 7.41% Upside In The Healthcare Sector - DirectorsTalk Interviews
An Inside Look at the Alcon-STAAR Surgical Deal Collapse - Medical Product Outsourcing
Alcon Inc (ALC) Stock Price Down 3.54% on Mar 2 - GuruFocus
Is Alcon (ALC) Stock Outpacing Its Medical Peers This Year? - Yahoo Finance
Alcon Surpasses 175 Million IOLs Implanted Globally - ChartMill
Alcon Stock After Earnings: Hidden Defensive Play for US Portfolios? - AD HOC NEWS
Alcon Eyes Cataract And Presbyopia Growth With LENSAR Deal And TOTAL30 - simplywall.st
Tariffs, Competition Ding Alcon’s Future - WFMZ.com
Equita SIM Upgrades Alcon to Buy, Raises PT - marketscreener.com
Analysts Conflicted on These Healthcare Names: Teladoc (TDOC) and Alcon (ALC) - The Globe and Mail
Wells Fargo Upgrades Alcon (ALC) - Nasdaq
This US Bancorp Analyst Turns Bullish; Here Are Top 4 Upgrades For Thursday - Benzinga
2026 DallasCISO ORBIE Awards Recognize Top Security Executives - GlobeNewswire Inc.
Barclays Maintains Rating for Alcon (ALC) and Raises Price Targe - GuruFocus
Today's Analyst Upgrade for Alcon (ALC) with New Price Target | - GuruFocus
Needham Raises Price Target on Alcon to $100 From $98, Keeps Buy Rating - marketscreener.com
Here Are Thursday’s Top Wall Street Analyst Research Calls: Alcon, First Solar, Five Below, Joby Aviation, Spotify, Trade Desk, U.S. Bancorp, and More - AOL.com
Wells Fargo upgrades Alcon stock rating on new product growth By Investing.com - Investing.com Nigeria
Nvidia To Rally More Than 53%? Here Are 10 Top Analyst Forecasts For Thursday - Benzinga
Alcon Inc. (NYSE:ALC) Q4 2025 Earnings Call Transcript - Insider Monkey
Alcon Estimates Tweaked as Bernstein Notes Potential Upside from End-market Recovery; Price Target Up - marketscreener.com
Wells Fargo upgrades Alcon stock rating on new product growth - Investing.com
ALC: Needham Maintains Buy Rating and Raises Price Target to $10 - GuruFocus
Alcon (ALC) Receives Upgrade as Growth Prospects Brighten - GuruFocus
Why Is Alcon Inc. (ALC) Stock Up Today? - Meyka
Lensar® provides update on pending acquisition by Alcon - marketscreener.com
Lensar® Provides Update On Pending Acquisition By Alcon - TradingView
LENSAR Updates Timeline for Pending Alcon Acquisition Review - TipRanks
Alcon Posts Strong Q4 2025 Sales Growth and Robust Cash Generation - The Globe and Mail
LENSAR-Alcon deal closing pushed to first half of 2026 - Investing.com
ALC.SW Alcon Inc. (SIX) ends CHF64.26 25 Feb 2026: heavy volume, earnings focus - Meyka
Lensar, Alcon still working on US FTC second request, aim to close before July - MLex
LENSAR Provides Update on Alcon Acquisition Status - Intellectia AI
LENSAR-Alcon deal closing pushed to first half of 2026 By Investing.com - Investing.com South Africa
LENSAR® Provides Update on Pending Acquisition by Alcon - The Manila Times
LENSAR Provides Update, Expects Alcon Acquisition to Close in H1 2026 Pending FTC Approval - TradingView
LENSAR, Inc. Provides Update on Acquisition Status by Alcon Research, LLC - Quiver Quantitative
Alcon (SWX:ALC) Margin Decline Tests Bullish Growth Narrative Despite Higher FY 2025 Revenue - simplywall.st
Alcon Inc (ALC) (Full Year 2025) Earnings Call Highlights: Strong Revenue Growth Amid Market ... By GuruFocus - Investing.com Canada
Eye-care group Alcon expects product launches to drive 2026 sales, profitability - whbl.com
Alcon (ALC) Q4 2025 Earnings Call Transcript - The Globe and Mail
Alcon (ALC) Reports Strong Q4 2025 Performance with 7% Sales Gro - GuruFocus
3.22%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):